Clinimetric measurement in traumatic brain injuries

Area of Science:

• Neurology
• Public Health
• Biomedical Science

Background:

• Traumatic brain injury (TBI) is a significant cause of global mortality and disability, disproportionately affecting low and middle-income countries.
• The long-term consequences of TBI include reduced quality of life, disability, and psychosocial challenges, making outcome prediction difficult.
• Current care costs are heavily influenced by the level of disability resulting from TBI.

Purpose of the Study:

• To review and present commonly used clinimetric scales for evaluating consciousness levels post-TBI.
• To highlight the importance of accurate prognostication in managing TBI patients.
• To discuss various markers aiding in predicting recovery after traumatic brain injury.

Main Methods:

• Review of existing literature on traumatic brain injury prognostication.
• Identification and presentation of established clinical predictors (age, Glasgow Coma Scale, pupil reactivity, extracranial injury).
• Compilation of neuroradiological markers (CT, MRI, PET) and biomarkers (ApoE, CD38, S100B, MBP, NSE, GFAP) relevant to TBI recovery.

Main Results:

• Several clinimetric scales are available for assessing consciousness after TBI.
• A combination of clinical factors, imaging, and biomarkers can aid in predicting TBI outcomes.
• Predicting the precise outcome after TBI remains a complex challenge.

Conclusions:

• Accurate prognostication is crucial for effective TBI management and resource allocation.
• The presented scales and markers offer valuable tools for assessing TBI severity and predicting recovery.
• Further research into predictive models can improve patient care and outcomes following traumatic brain injury.